These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35584501)

  • 1. Hepatocellular carcinoma versus nonalcoholic fatty liver disease: metabolic, environmental, and genetic association? De facto?
    Toman D; Sengul I; Pelikán A; Sengul D; Vavra P; Ihnát P; Roman J; Kayaalp C
    Rev Assoc Med Bras (1992); 2022 May; 68(5):708-711. PubMed ID: 35584501
    [No Abstract]   [Full Text] [Related]  

  • 2. A narrative review on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis versus hepatocellular carcinoma: do you mind?
    Toman D; Sengul I; Pelikán A; Sengul D; Vavra P; Ihnat P; Roman J; Kayaalp C
    Rev Assoc Med Bras (1992); 2022; 68(6):871-874. PubMed ID: 35766704
    [No Abstract]   [Full Text] [Related]  

  • 3. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.
    Yeh MM; Liu Y; Torbenson M
    Hum Pathol; 2015 Nov; 46(11):1769-75. PubMed ID: 26410018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glyphosate Excretion is Associated With Steatohepatitis and Advanced Liver Fibrosis in Patients With Fatty Liver Disease.
    Mills PJ; Caussy C; Loomba R
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):741-743. PubMed ID: 30954713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
    Dongiovanni P; Romeo S; Valenti L
    World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
    Wu J
    Oncotarget; 2016 Jul; 7(27):42762-42776. PubMed ID: 27072576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns.
    Zeng F; Zhang Y; Han X; Zeng M; Gao Y; Weng J
    Front Immunol; 2020; 11():609900. PubMed ID: 33574818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma.
    Takakura K; Oikawa T; Tomita Y; Mizuno Y; Nakano M; Saeki C; Torisu Y; Saruta M
    World J Gastroenterol; 2018 May; 24(18):1989-1994. PubMed ID: 29760542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease.
    Ramai D; Facciorusso A; Vigandt E; Schaf B; Saadedeen W; Chauhan A; di Nunzio S; Shah A; Giacomelli L; Sacco R
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
    Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of nonalcoholic fatty liver disease (NAFLD).
    Yki-Järvinen H
    Duodecim; 2016; 132(22):2099-106. PubMed ID: 29190058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to: Non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back?
    Pavlides M; Mózes FE; Harrison SA
    Gut; 2022 Jul; 71(7):1453-1454. PubMed ID: 34706868
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonalcoholic Fatty Liver Disease vs. Nonalcoholic Steatohepatitis: Pathological and Clinical Implications.
    Boutari C; Lefkos P; Athyros VG; Karagiannis A; Tziomalos K
    Curr Vasc Pharmacol; 2018; 16(3):214-218. PubMed ID: 28676025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
    Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
    Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty Liver Disease and Hepatocellular Carcinoma: The Pathologist's View.
    Tiniakos DG; Maurício J; Reeves HL
    Adv Exp Med Biol; 2018; 1032():55-69. PubMed ID: 30362090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KLF6 in nonalcoholic fatty liver disease: role of fibrogenesis and carcinogenesis.
    Watanabe K; Ohnishi S; Manabe I; Nagai R; Kadowaki T
    Gastroenterology; 2008 Jul; 135(1):309-12. PubMed ID: 18558090
    [No Abstract]   [Full Text] [Related]  

  • 19. MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model.
    Sakamoto H; Miyanishi K; Tanaka S; Ito R; Hamaguchi K; Sakurada A; Sato M; Kubo T; Osuga T; Murase K; Takada K; Nakabeppu Y; Kobune M; Kato J
    Sci Rep; 2021 Feb; 11(1):3599. PubMed ID: 33574380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Non-alcoholic Fatty Liver Disease in North America.
    Arshad T; Golabi P; Henry L; Younossi ZM
    Curr Pharm Des; 2020; 26(10):993-997. PubMed ID: 32124690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.